Salvage of a Distal Ulnar Nonunion with Teriparatide Therapy
Abstract
We present an 80-year-old woman with osteoporosis who sustained a fall, resulting in a closed left distal radius fracture and a grade I open ulna fracture. She underwent open reduction internal fixation. Four months later, the radius healed, but the ulna showed delayed union. Initial bone stimulator therapy was ineffective, and computed tomography scans confirmed nonunion at 6 and 9 months after surgery. Revision surgery was considered, but her treatment was changed to teriparatide, a parathyroid hormone analog that stimulates bone healing. Within 2 months, progressive ulnar healing was noted, avoiding revision surgery. At 15 months, x-rays confirmed full healing, and the patient resumed weight-bearing. This case underscores teriparatide as a promising nonsurgical option for fracture nonunion in osteoporotic patients, meriting further research.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.